Stocks and Investing
Stocks and Investing
Thu, October 19, 2017
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
Wed, October 18, 2017
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
Andrew Baum Maintained (BMY) at Strong Buy with Increased Target to $72 on, Oct 18th, 2017
Andrew Baum of Citigroup, Maintained "Bristol-Myers Squibb Company" (BMY) at Strong Buy with Increased Target from $55 to $72 on, Oct 18th, 2017.
Andrew has made no other calls on BMY in the last 4 months.
There are 6 other peers that have a rating on BMY. Out of the 6 peers that are also analyzing BMY, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Holford of "Jefferies" Downgraded from Strong Buy to Hold on, Monday, October 16th, 2017
- Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $65 on, Friday, October 13th, 2017
- Gregg Gilbert of "Deutsche Bank" Maintained at Hold with Increased Target to $55 on, Monday, July 17th, 2017
These are the ratings of the 3 analyists that currently disagree with Andrew
- Marc Goodman of "UBS" Maintained at Strong Buy with Increased Target to $72 on, Friday, October 6th, 2017
- Seamus Fernandez of "Leerink Swann" Maintained at Buy with Decreased Target to $61 on, Friday, July 28th, 2017
- Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $49 on, Friday, July 28th, 2017